Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
8.75
-0.17 (-1.91%)
Nov 20, 2024, 4:00 PM EST - Market closed
Aura Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 437 | 436 | 389 | 496 | - | - |
| Market Cap Growth | 29.00% | 12.22% | -21.59% | - | - | - |
| Enterprise Value | 282 | 308 | 298 | 631 | - | - |
| Last Close Price | 8.75 | 8.86 | 10.50 | 16.98 | - | - |
| PB Ratio | 2.49 | 1.93 | 1.99 | 3.26 | - | - |
| P/TBV Ratio | 2.53 | 1.93 | 1.99 | 3.26 | - | - |
| Debt / Equity Ratio | 0.11 | 0.09 | 0.11 | 0.01 | - | 0.00 |
| Quick Ratio | 11.85 | 18.30 | 18.06 | 20.27 | 6.54 | 5.28 |
| Current Ratio | 12.47 | 18.76 | 18.81 | 20.90 | 6.94 | 5.42 |
| Return on Equity (ROE) | -50.99% | -36.26% | -33.78% | -41.07% | -88.60% | - |
| Return on Assets (ROA) | -30.22% | -22.18% | -19.63% | -24.19% | -46.92% | - |
| Return on Capital (ROIC) | -31.82% | -23.00% | -20.38% | -25.52% | -55.32% | - |
| Earnings Yield | -19.04% | -17.51% | -15.11% | -7.11% | - | - |
| FCF Yield | -17.05% | -14.79% | -14.32% | -6.96% | - | - |
| Buyback Yield / Dilution | -32.55% | -32.34% | -480.18% | -1305.21% | -8.54% | - |
| Total Shareholder Return | -32.55% | -32.34% | -480.18% | -1305.21% | -8.54% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.